what is the safest glp-1 drug List of approved and pending medications GLP-1 Drugs from the Gray

Patients on DPP-4 inhibitors (such as sitagliptin for type 2 diabetes) may therefore experience prolonged peptide exposure, an interaction not yet formally studied but mechanistically plausible

BPC-157 The Healing Peptide Annaelle Lamers PA-C Sep 2, 2025 4 min read Updated: Sep 3, 2025 For most people, healing feels frustratingly slow

Retatrutide Phase 2 Efficacy Data The phase 2 dose-ranging trial (ClinicalTrials.gov NCT04881760, published in the New England Journal of Medicine in 2023) enrolled 338 adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity, and randomized them to placebo or retatrutide 1 mg, 4 mg, 8 mg, or 12 mg weekly after a structured titration period of up to 24 weeks [1]

Usually the nausea is only caused by taking too large of a dose than your body is ready for though anyways, and all negative side effects should disappear over a short span of time

It remains a critical addition to peptide libraries focused on regenerative biology, follicular research, and anti-aging peptide studies